Language selection

Government of Canada / Gouvernement du Canada

Search

Cost drivers for Canada's public and private drug plans during the COVID-19 pandemic : a 2019-2022 comparative analysis / Yvonne Zhang = Facteurs de coût des régimes d'assurance-médicaments publics et...: H82-57/2024-PDF

"Canadian public drug plans and private insurers together account for over three quarters of all prescribed drug spending in Canada. This poster sheds light on the differences and similarities between key cost pressures for public and private drug plans, differentiating between short-term effects and those with longer-lasting impacts. The study spans from 2019, before the COVID-19 pandemic, to 2022, with a retrospective look at recent trends and highlights the impact of the pandemic on Canadian drug spending"--Introduction, page [1].

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.954007&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board, issuing body.
TitleCost drivers for Canada's public and private drug plans during the COVID-19 pandemic : a 2019-2022 comparative analysis / Yvonne Zhang = Facteurs de coût des régimes d'assurance-médicaments publics et privés du Canada pendant la pandémie de COVID-19 : une analyse comparative 2019-2022 / Yvonne Zhang.
Variant title
  • Facteurs de coût des régimes d'assurance-médicaments publics et privés du Canada pendant la pandémie de COVID-19 : une analyse comparative 2019-2022
Publication typeMonograph
LanguageBilingual-[English | French]
FormatDigital text
Electronic document
Parallel description[French]
Note(s)
  • Caption title.
  • "NPDUIS, National Prescription Drug Utilization Information System, "Supporting health care decision making in Canada" = SNIUMP, Le Système national d'information sur l'utilisation des médicaments prescrits, « Appuyer les décisions en matière des soins de santé au Canada »"
  • Includes bibliographical references.
  • Text in English and French.
Publishing information
  • [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2024]
Author / Contributor
  • Zhang, Yvonne, author.
Description1 online resource (1 unnumbered page) : graphs
Catalogue number
  • H82-57/2024-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: